EDGAR Filing Documents for 0001144204-17-028931

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001144204-17-028931

Filing Date

2017-05-22

Accepted

2017-05-22 17:28:22

Documents

Period of Report

2017-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	10-Q	v466378_10q.htm	10-Q	459849
2	EXHIBIT 10.3	v466378_ex10-3.htm	EX-10.3	55471
3	EXHIBIT 31.1	v466378_ex31-1.htm	EX-31.1	9858
4	EXHIBIT 31.2	v466378_ex31-2.htm	EX-31.2	10048
5	EXHIBIT 32.1	v466378_ex32-1.htm	EX-32.1	4071
6	EXHIBIT 32.2	v466378_ex32-2.htm	EX-32.2	4077
	Complete submission text file	0001144204-17-028931.txt		2972940

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	svon-20170331.xml	EX-101.INS	447516
8	XBRL TAXONOMY EXTENSION SCHEMA	svon-20170331.xsd	EX-101.SCH	33091
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	svon-20170331_cal.xml	EX-101.CAL	34559
10	XBRL TAXONOMY EXTENSION DEFINITION LINKBASE	svon-20170331_def.xml	EX-101.DEF	228501
11	XBRL TAXONOMY EXTENSION LABEL LINKBASE	svon-20170331_lab.xml	EX-101.LAB	265395
12	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	svon-20170331_pre.xml	EX-101.PRE	256649

Mailing Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121

Business Address 10210 CAMPUS POINT DRIVE, SUITE 150 SAN DIEGO CA 92121 (908) 864-4444

Sevion Therapeutics, Inc. (Filer) CIK: 0001035354 (see all company filings)